Background: Sera from patients with periodontal infections contain elevated levels of C-reactive protein (CRP) compared to periodontally healthy individuals. Most studies to date have included patients with chronic periodontitis, and few investigators have studied CRP levels in subjects with aggressive periodontitis (AgP). The purpose of this study was to determine the relative levels of serum CRP in AgP patients and periodontally healthy subjects and to examine patients' characteristics that might account for intergroup differences.
T here is evidence that periodontitis and coronary artery disease (CAD) are linked by inflammatory factors, including C-reactive protein (CRP). CRP is an acute-phase reactant that is produced in response to diverse inflammatory stimuli, including heat, trauma, infection, and hypoxia. CRP levels provide useful information for the diagnosis, monitoring, and therapy of the inflammatory process and associated disease. [1] [2] [3] [4] CRP levels rise in serum or plasma within 24 to 48 hours following acute tissue damage, reach a peak during the acute stage (as high as a thousand-fold), and decrease with the resolution of inflammation or trauma. 2, 4 CRP plays a key role in the innate immune response and is easily measured due to its long plasma half-life (12 to 18 hours). 5 In healthy individuals, CRP levels are found in trace amounts with levels <0.3 mg/l. [6] [7] [8] Serum levels of CRP could exceed 100 mg/l in the presence of overwhelming systemic infection, which provides a useful marker for tracking the course of the infection. 9 Recent studies have demonstrated a correlation between periodontitis and elevated CRP levels. In 2000, Slade et al. 9 found that after controlling for established risk factors, increased levels of CRP persisted among individuals with extensive periodontal disease. In fact, among dentate individuals with extensive periodontal disease, an increase of approximately one-third in mean CRP and a doubled prevalence of elevated CRP were found compared to periodontally healthy subjects. However, in this study, CRP levels below 3 mg/l were not studied, and the population was taken from the National Health and Nutrition Examination Survey (NHANES) III database. Glurich et al. 10 found that localized persistent infection could influence systemic levels of inflammatory mediators. Subjects with periodontal disease and cardiovascular disease (CVD) demonstrated higher levels of CRP than subjects with CVD and no periodontitis. Additionally, Noack et al. 11 found a significant increase in adjusted mean levels of CRP in subjects with high attachment loss (AL) (4.06 -5.55 mg/l) compared to control subjects (1.70 -1.91 mg/l). A correlation was found between subgingival microorganisms (Porphyromonas gingivalis, Prevotella intermedia, Campylobacter rectus, and Tannerella forsythensis) and elevated levels of CRP. These studies show a significant correlation between elevated CRP and chronic periodontitis.
Atherosclerosis and CAD are chronic inflammatory disorders that are initiated by vascular injury induced by a number of factors. CAD is the number one cause of morbidity and mortality worldwide. 12 Recent studies showed that CRP is a strong predictor of future coronary artery events in healthy men and women. However, the relative risk of CVD as determined by CRP levels is independent of other CVD risk factors. Ridker et al. 13 subdivided CRP levels into quintiles and found that the relative risks following adjustments for a first cardiovascular event for women were 1.4, 1.6, 2.0, and 2.3 for these respective quintiles (>0.45 to 1.08 mg/l, >1.08 to 2.09 mg/l, >2.09 to 4.19 mg/l, and >4.19 mg/l). This study showed that CRP was a stronger predictor of cardiovascular events than low-density lipoprotein cholesterol. The predictive value of CRP levels above or below 3 mg/l in terms of first cardiovascular event was similar to the predictive value associated with having or not having three or more characteristics of metabolic syndrome (upperbody obesity, hypertriglyceridemia, low high-density lipoprotein, hypertension, and abnormal glucose). 5 Age-adjusted relative risks of future cardiovascular events for women in the low-CRP/no metabolic syndrome, high-CRP/no metabolic syndrome, low-CRP/ with metabolic syndrome, and high-CRP/with metabolic syndrome groups were 1.0, 1.5 (95% confidence interval [CI]: 1.0 to 2.2), 2.3 (95% CI: 1.6 to 3.3), and 4.0 (95% CI: 3.0 to 5.4), respectively. Thus, CRP consistently added prognostic information to metabolic syndrome regardless of its severity in the prediction of future cardiovascular events. 5 The purpose of this study was to determine the relative levels of serum CRP in aggressive periodontitis (AgP) patients and age-matched controls and to examine patients' characteristics that might account for intergroup differences.
MATERIALS AND METHODS

Patient Selection and Clinical Examination
All subjects were ascertained by the Virginia Commonwealth University Clinical Research Center for Periodontal Disease Database. This study was approved by the Virginia Commonwealth University internal review board, and all patients signed an informed consent form. A total of 281 subjects seen at the Clinical Research Center for Periodontal Disease, Virginia Commonwealth University, between 1984 and 2002 had a medical history obtained by questionnaire and interview, complete dental exam, and matching serum samples with clinical exam. Complete examinations consisted of suppuration index (a dichotomous index determined by elicitation of purulent exudate following gentle pressure with a ball burnisher), plaque index (PI), 14 gingival index (GI), 15 probing depth (PD), bleeding index (BI; a dichotomous index determined by observation of bleeding within 20 seconds following periodontal probing), and AL measurements. Missing and deciduous teeth were also recorded. The clinical examination was performed at four sites per tooth (mesio-buccal, buccal, disto-buccal, and lingual) with a color-coded probe. § Diabetic subjects and subjects with reported arthritis were eliminated from the database. All examiners were calibrated to verify reliability. 16 Subjects were placed into diagnostic groups according to the following definitions.
Non-periodontitis (NP). This group comprised 91 patients with no evidence of AL, except for recession on the buccal side of anterior teeth, at more than one site, or pockets >3 mm. Gingival inflammation may have been present in variable degrees of severity.
Generalized AgP (GAgP). A total of 93 subjects with generalized pattern of severe periodontal destruction with AL of at least 5 mm on eight or more teeth, at least three of which are not first molars and incisors, were included in this group. Demonstrated age of onset was under 35 years.
Localized AgP (LAgP). The LAgP group comprised 97 subjects with localized pattern of clinical AL limited to first molar or incisor teeth and up to two additional teeth. Demonstrated age of onset was under 30 years.
Quantitative Determination of CRP Concentration in Serum Serum levels of CRP were quantified using a highsensitivity CRP enzyme-linked immunosorbent assay (hsCRP ELISA) test kit according to the manufacturer's instructions. i Lower limits of hsCRP ELISA were ;0.1 mg/l CRP, and the upper limits were 10 mg/l CRP. All samples were run in duplicate. § PCP 12, Hu-Friedy, Chicago, IL. i BioCheck, Burlingame, CA.
Statistical Methods
For unadjusted analyses, nominal characteristics of groups were compared using the x 2 test, and continuous characteristics were compared using analysis of variance (ANOVA). Differences between the groups were identified by Tukey's honestly significant difference (HSD) multiple comparison procedure. Because the CRP values were strongly skewed, the log-transformed values were analyzed. The backtransformed least square means and 95% CIs thus provide estimates of the geometric means of the groups.
RESULTS
The patient characteristics of the three groups are summarized in Table 1 , which shows that the groups were different with respect to race, gender, smoking habits, age, number of teeth, PD, AL, PI, GI, and BI. The racial compositions of the subject groups differed with a smaller percentage of periodontally healthy (NP) subjects being black than the LAgP and GAgP subjects. One LAgP subject was of Asian descent. There was a higher proportion of males in the control group (52%) compared to 36% in the LAgP group and 31% in the GAgP group. More smokers were seen in the GAgP group compared to the NP group, with the lowest proportion of smokers in the LAgP group.
The mean age in the LAgP subjects was younger than the NP and GAgP groups. As expected, all groups were different with respect to clinical characteristics, with generally more severe clinical indices in the GAgP group and less severe indices in the control group.
The mean CRP levels for the NP, LAgP, and GAgP groups, as seen in Table 2 , were 1.54 mg/l, 2.57 mg/l, and 3.72 mg/l, respectively. Figure 1 shows the distribution of CRP levels in the three diagnostic groups, with the geometric mean indicated for each group. Because the CRP values were strongly skewed, statistical analyses were performed on the log-transformed * The NP subjects were significantly different from the others, and the LAgP and GAgP subjects were not different from each other (P <0.05). † The GAgP subjects were significantly different from the others, and the NP and LAgP subjects were not different from each other (P < 0.05). ‡ The LAgP subjects were significantly different from the others, and the NP and GAgP subjects were not different from each other (P < 0.05). § Each of the three subject groups was statistically different from one another. data. As shown in Table 3 , log CRP values of the three patient groups were significantly different from each other (P <0.0001), with CRP levels in the GAgP group greater than those in the LAgP, which were in turn greater than those in the NP subjects. Furthermore, log CRP was significantly associated with the clinical characteristics, as seen in Table 4 . Specifically, increased levels of CRP were associated with increased age, number of teeth, PD, AL, PI, GI, and BI.
Finally, we performed a multivariate regression analysis adjusting for significant demographic and clinical variables identified in the univariate analyses. The results of this adjusted model (Table 5) indicated that only periodontal diagnosis and average PD were significantly related to log CRP following correction for other study variables. In this adjusted analysis, the NP subjects had significantly lower CRP than did the other CRP serum concentrations in NP, LAgP, and GAgP subjects. The mean and 95% CI are shown for each subject group. two groups. PD explained the difference between the LAgP and GAgP groups.
DISCUSSION
Previous studies of acute-phase reactants in periodontitis have focused on patients with chronic periodontitis. 10, 11, [17] [18] [19] [20] [21] [22] [23] [24] [25] For the most part, such studies have demonstrated that CRP levels are higher in periodontitis patients than in periodontally healthy subjects and that serum CRP levels are higher in patients with more severe periodontitis. In addition, recent trials have indicated that treatment of periodontal infections, whether by intensive mechanical therapy, drug therapy, or extraction, can significantly lower serum levels of CRP. [26] [27] [28] [29] [30] Such studies implicate periodontal infection or its resultant inflammatory response as a source of systemic elevation of CRP.
To our knowledge, our data are the first to demonstrate that patients with AgP demonstrate elevated serum concentrations of CRP. The cohort of AP subjects used were ascertained using age of disease onset as a diagnostic criterion; thus, the group displays younger age range than that seen in studies of CP. Therefore, this study demonstrates that periodontitis can impact systemic markers of inflammation in a relatively young subject group. It is also noted that patients did not require generalized severe disease to demonstrate elevated CRP concentrations. Thus, even LAgP subjects with relatively low whole-mouth mean PD and AL measures have higher CRP levels than healthy controls. The aggressive nature of this disease appears to be sufficient to influence the acute-phase response despite the localized nature of its occurrence.
Our results confirm the hypothesis that AgP is significantly related to elevated CRP levels. The GAgP (3.72 mg/l) group had significantly elevated levels of CRP compared to the LAgP (2.57 mg/l) and NP (1.54 mg/l) groups. None of the subjects in this study had CRP levels >15 mg/l, indicating that it is relatively unlikely that the subjects were experiencing acute or chronic systemic diseases characterized by large increases in serum CRP. Although most of the measured clinical indices were found to be associated with CRP levels in univariate analyses, multivariate analysis correcting for demographic and periodontal variables revealed that increased PD remained significantly associated with elevated CRP concentrations. This result is consistent with the interpretation that the surface area or volume of the periodontal lesion is the most important determinant of serum CRP levels in AP patients.
Our data for AP patients are in concert with previous studies in which a relationship between chronic periodontitis and elevated levels of CRP was demonstrated. For example, Slade et al. 9 demonstrated that edentulism and periodontitis were associated with increased CRP levels. In subjects with periodontitis, the magnitude of the association was comparable to that identified for conditions such as chronic bronchitis and smoking. The study used the NHANES III database, which has inherent limitations, and CRP levels <3 mg/l were not measured. Glurich et al. 10 found significantly elevated CRP levels in subjects with bleeding on probing and mean AL of ‡4 mm. A correlation between elevated levels of CRP and CVD was also demonstrated in subjects with periodontal disease compared to subjects with cardiovascular disease and no periodontitis. Noack et al. 11 found a significant increase in adjusted mean levels of CRP in subjects with 3 mm mean AL. In addition, CRP levels were not compared to other clinical parameters, and no relationship was found between CRP and smoking. In a group of patients with chronic periodontitis, we have noted that CRP levels average 2.8 mg/l (unpublished data), which was significantly greater than levels in NP subjects and intermediate between levels noted in LAgP and GAgP subjects. Thus, relative CRP levels in these patient groups are consistent with the extent and severity of these disease subforms.
Elevation of CRP levels in various forms of periodontal disease may be indicative of an underlying pathway in the association between periodontal disease and CVD. 13 In addition to serving as an indicator of risk for CVD, CRP also displays biologic functions that are likely to promote the pathology of cardiovascular lesions. CRP functions in innate immunity as an opsonin that binds to the phosphorylcholine present on many cell types, including bacteria and apoptotic cells, 31, 32 and activates the complement system. Recent studies demonstrate that CRP likewise opsonizes oxidized low-density lipoproteins 33 and can be shown to colocalize with complement proteins in atherosclerotic lesions. 34 Thus, it is possible that CRP contributes to the formation of foam cells during the initiation of atheroma formation. 35 Studies have indicated that elevations in CRP in patients with periodontitis are likely additive to levels independently measured due to CVD alone. 10, 11, 36 Furthermore, recent studies indicate that periodontal therapy may result in decreased systemic levels of CRP. 26 Therefore, elevation of CRP such as that seen in periodontal diseases may supplement systemic vascular inflammation and atheroma formation and add to preexisting risk for cardiovascular sequellae. This may be of particular concern in younger individuals, as represented by AP patients where elevated levels of CRP due to periodontitis may contribute to early or more rapid CVD in susceptible patients. Future studies will focus on the relationship between periodontitis, elevated CRP levels, and the effect of periodontal therapy on serum CRP concentration. 
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